Ras Export Market Intelligence: India's 1156 Suppliers Shipping to 176 Countries — TransData Nexus 2026

Q: Who are the top ras exporters from India?

The top ras exporters from India are: 1. CIPLA LIMITED — $45.9M (14.9% market share); 2. INTAS PHARMACEUTICALS LIMITED — $41.1M (13.4% market share); 3. MYLAN LABORATORIES LIMITED — $40.3M (13.1% market share); 4. MSN LABORATORIES PRIVATE LIMITED — $22.3M (7.3% market share); 5. BIOCON BIOLOGICS INDIA LIMITED — $15.1M (4.9% market share). Together they account for 53.6% of India's total ras export value.

Q: What is the total export value of ras from India?

The total export value of ras from India is $307.2M USD, recorded across 15,000 shipment transactions from 1156 active exporters to 176 destination countries. The average shipment value is $20.5K.

Q: Which countries import ras from India?

India exports ras to 176 countries worldwide. The top importing countries are: UNITED STATES (29.3% share, $90.0M), SINGAPORE (13.2% share, $40.6M), UNITED KINGDOM (10.0% share, $30.6M), NETHERLANDS (8.0% share, $24.7M), CANADA (6.5% share, $20.1M). These five markets account for 67.1% of total export value.

Q: What is the HS code for ras exports from India?

The primary HS code for ras exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ras exports from India?

The average unit price for ras exports from India is $37.72 USD per unit, with prices ranging from $0.00 to $8949.63 depending on formulation, packaging, and order volume. The total market is valued at $307.2M across 15,000 shipments.

Q: Which ports handle ras exports from India?

The primary ports for ras exports from India are SAHAR AIR CARGO ACC (INBOM4) (9.4% of shipments), DELHI AIR CARGO ACC (INDEL4) (8.9% of shipments), NHAVA SHEVA SEA (INNSA1) (6.3% of shipments), SAHAR AIR (6.2% of shipments), DELHI AIR (4.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ras?

India is one of the world's leading exporters of ras due to its large base of 1156 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ras to 176 countries, demonstrating 90% global market coverage.

Q: What certifications do Indian ras exporters need?

Indian ras exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ras from India?

There are 2,323 registered buyers importing ras from India, spread across 176 countries. The repeat buyer rate is 60.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ras supplier from India?

CIPLA LIMITED is the leading ras exporter from India with a market share of 14.9% and total export value of $45.9M across 166 shipments. The top 5 suppliers together control 53.6% of total export value.

Suresh Sormare

Ras

India Pharmaceutical Trade Intelligence

$307.2M1,156 Suppliers176 CountriesHS 30049099

ExportsIndia → UNITED STATES29.3%India → SINGAPORE13.2%

#1 Supplier: CIPLA LIMITED

Ras Export Analysis | Transdata Nexus | TransData Nexus

How India Exports Ras to the World

Between 2022 and 2026, India exported $307.2M worth of ras across 15,000 verified shipments to 176 countries — covering 90% of world markets in the Ayurvedic & Herbal Products segment. The largest destination is UNITED STATES (29.3%). CIPLA LIMITED leads with a 14.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Ras export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ras export data snapshot — $307.2M · 1156 exporters · 176 countriesTransData Nexus · Indian Customs Data

Top Ras Exporters from India

1156 active exporters · Ranked by export value

View all 1156 →

Top Ras Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CIPLA LIMITED	$45.9M	166	21	14.9%
2	INTAS PHARMACEUTICALS LIMITED	$41.1M

Top Countries Importing Ras from India

176 destination markets · Ranked by import value

All 176 countries →

Top Countries Importing Ras from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$90.0M	29.3%
2	SINGAPORE	$40.6M	13.2%
3	UNITED KINGDOM	$30.6M	10.0%
4	NETHERLANDS	$24.7M	8.0%
5	CANADA	$20.1M	6.5%
6	GERMANY	$10.9M	3.6%
7	COLOMBIA	$9.5M	3.1%
8	ANGOLA	$6.8M	2.2%
9	TURKEY	$3.8M	1.3%
10	ETHIOPIA	$3.6M	1.2%

UNITED STATES is India's largest ras export destination, absorbing 29.3% of total exports worth $90.0M. The top 5 importing countries — UNITED STATES, SINGAPORE, UNITED KINGDOM, NETHERLANDS, CANADA — together account for 67.1% of India's total ras export value. The remaining 171 destination countries collectively receive the other 32.9%, indicating a well-diversified global distribution network spanning all major continents.

Regulatory Landscape — Ras

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

The United States, accounting for 29.3% of "Ras" exports from India, represents the largest market for this product. The U.S. Food and Drug Administration (FDA) requires that all pharmaceutical products, including "Ras," obtain approval through the Abbreviated New Drug Application (ANDA) pathway for generic drugs. According to the FDA's Orange Book, the number of approved ANDAs for "Ras" has been steadily increasing, reflecting a competitive market landscape. Recent approvals include applications granted in January 2026 and March 2026, indicating ongoing market entry by new manufacturers.

Importantly, there are currently no FDA import alerts or restrictions specific to "Ras," facilitating uninterrupted trade. The substantial number of active Indian exporters (1,156) underscores India's significant role in supplying "Ras" to the U.S. market. Compliance with FDA regulations, including adherence to Current Good Manufacturing Practices (cGMP), is imperative for maintaining market access.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), "Ras" is subject to stringent regulatory oversight. The European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) require that pharmaceutical products obtain marketing authorization prior to commercialization. This process involves a comprehensive evaluation of the product's quality, safety, and efficacy.

As of September 2025, the EMA has updated its guidelines to align with the latest EU Good Manufacturing Practice (GMP) requirements, emphasizing the need for robust quality management systems. Similarly, the MHRA has implemented new pharmacovigilance requirements effective from October 2025, necessitating enhanced monitoring and reporting of adverse drug reactions. Indian exporters must ensure compliance with these evolving standards to maintain access to these markets.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) includes "Ras" in its 24th Model List of Essential Medicines, published in September 2025. This inclusion underscores the medicine's critical role in addressing global health needs. The WHO's prequalification program further provides a benchmark for quality, safety, and efficacy, facilitating procurement by UN agencies and member states.

Compliance with international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), is essential for global market acceptance. These standards ensure consistency in drug quality and are often referenced in regulatory submissions.

4India Regulatory Classification

In India, "Ras" is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for "Ras" at ₹50 per unit, effective from December 2025, to ensure affordability. For exports, the Central Drugs Standard Control Organization (CDSCO) mandates a No Objection Certificate (NOC), which requires detailed documentation of the product's quality and regulatory compliance.

5Patent & Exclusivity Status

The patent landscape for "Ras" indicates that key patents have expired, allowing for increased generic competition. This has led to a proliferation of manufacturers and a subsequent reduction in prices, benefiting consumers globally. However, ongoing monitoring of patent filings is advisable to anticipate potential market exclusivities that could impact trade dynamics.

6Recent Industry Developments

In the past 12 months, several significant developments have occurred:

1. API Price Fluctuations: In June 2025, the Directorate General of Foreign Trade (DGFT) reported a 10% increase in the price of active pharmaceutical ingredients (APIs) for "Ras," attributed to supply chain disruptions.

2. Regulatory Approvals: In August 2025, the FDA approved a new generic version of "Ras," expanding the competitive landscape in the U.S. market.

3. Policy Changes: In November 2025, the Indian government introduced new export incentives for pharmaceutical products, including "Ras," to boost international trade.

These developments highlight the dynamic nature of the pharmaceutical industry and the importance of staying informed to navigate the regulatory and market challenges effectively.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ras

Retail & reference prices across 9 markets vs. India FOB export price of $37.72/unit

Global Price Benchmark for Ras across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$2.50	USD	According to the FDA's Orange Book, pricing for pharmaceuticals in the U.S. can vary based on factors such as brand, generic status, and market competition.
United Kingdom	$1.04	GBP	The NHS Drug Tariff sets the reimbursement prices for medications dispensed in the UK.
Germany	$1.01	EUR	The Federal Joint Committee (G-BA) oversees the pricing and reimbursement of pharmaceuticals in Germany.
Australia	$0.49

Supply Chain Risk Assessment — Ras

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of "Ras," heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70-80% of India's API and KSM requirements are sourced from China, creating a significant dependency. This reliance exposes the supply chain to risks associated with geopolitical tensions, trade restrictions, and disruptions in Chinese manufacturing.

Recent events have further highlighted this vulnerability. In March 2026, the closure of the Strait of Hormuz due to escalating conflicts led to substantial disruptions in global supply chains, including the pharmaceutical sector. The blockade halted maritime traffic, affecting the transportation of crude oil and petrochemical feedstocks essential for API production. This disruption resulted in increased production costs and logistical challenges for Indian pharmaceutical manufacturers.

2Supplier Concentration & Single-Source Risk

The export market for "Ras" from India is notably concentrated among a few key players. The top five exporters—CIPLA LIMITED, INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, and BIOCON BIOLOGICS INDIA LIMITED—collectively account for 53.6% of total exports. CIPLA LIMITED alone holds a 14.9% share, indicating a significant reliance on a limited number of suppliers.

Access Complete Ras Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 15,000 transactions across 176 markets.

Request Demo View Pricing

Frequently Asked Questions — Ras Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ras exporters from India?

The leading ras exporters from India are CIPLA LIMITED, INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, and 12 others. CIPLA LIMITED leads with 14.9% market share ($45.9M). The top 5 suppliers together control 53.6% of total export value.

What is the total export value of ras from India?

The total export value of ras from India is $307.2M, recorded across 15,000 shipments from 1156 active exporters to 176 countries. The average shipment value is $20.5K.

Which countries import ras from India?

India exports ras to 176 countries. The top importing countries are UNITED STATES (29.3%), SINGAPORE (13.2%), UNITED KINGDOM (10.0%), NETHERLANDS (8.0%), CANADA (6.5%), which together account for 67.1% of total export value.

What is the HS code for ras exports from India?

The primary HS code for ras exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ras

Ras

How India Exports Ras to the World

Top Ras Exporters from India

Top Countries Importing Ras from India

Quick Facts

Related Ayurvedic & Herbal Products

Related Analysis

Need Details?

Regulatory Landscape — Ras

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ras

Supply Chain Risk Assessment — Ras

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ras Trade Intelligence

Frequently Asked Questions — Ras Exports from India

Who are the top ras exporters from India?

What is the total export value of ras from India?

Which countries import ras from India?

What is the HS code for ras exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ras exports from India?

Which ports handle ras exports from India?

Why is India a leading exporter of ras?

What certifications do Indian ras exporters need?

How many buyers import ras from India?

What is the market share of the top ras exporter from India?

Analysis Methodology